Viemed reports Q1 2025 revenue of $59.1M, up 17% YoY; net income rises 64%

VIEMED HEALTHCARE, INC.

2025-Q1 EPS reported $0.06 revenue$59,129,000

Q1 net revenues $59.1M, 17% increase from $50.6M in Q1 2024.
Net income $2.6M ($0.06 diluted EPS) vs $1.6M ($0.04) prior year, up 64%.
Adjusted EBITDA $12.8M, 26% higher than $10.2M in Q1 2024.
Company provided updated full-year 2025 guidance alongside Q1 results.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.